Skip to search formSkip to main contentSkip to account menu

Immunogenicity Study

Known as: IMMUNOGENICITY 
A study that assesses an agent's ability to provoke an immune response (humoral and/or cell-mediated) in the subject.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SDTM Trial Type TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Influence of protein fold stability on immunogenicity and its implications for vaccine design
ABSTRACT Introduction: In modern vaccinology and immunotherapy, recombinant proteins more and more replace whole organisms to… 
Review
2016
Review
2016
Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application.
Review
2016
Review
2016
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
Cancer immunotherapy is currently the hottest topic in the oncology field, owing predominantly to the discovery of immune… 
Review
2016
Review
2016
From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals
Unlike conventional chemical drugs where immunogenicity typically does not occur, the development of anti‐drug antibodies… 
Review
2016
Review
2016
Recent advances in the production of recombinant subunit vaccines in Pichia pastoris
ABSTRACT Recombinant protein subunit vaccines are formulated using defined protein antigens that can be produced in heterologous… 
Review
2015
Review
2015
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
Biopharmaceuticals (BPs) represent a rapidly growing class of approved and investigational drug therapies that is contributing… 
Review
2015
Review
2015
Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults
Flublok is the first recombinant hemagglutinin (HA) vaccine licensed by the US Food and Drugs Administration for the prevention… 
Highly Cited
2014
Highly Cited
2014
A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China.
Highly Cited
2012
Highly Cited
2012
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine: an open-labeled, randomized trial in healthy Korean children
Purpose This study (NCT00751348) evaluated the immunogenicity and safety of a combined measles-mumps-rubella-varicella (MMRV… 
Highly Cited
2010
Highly Cited
2010
Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients
AIMS Catumaxomab is the first EMEA approved trifunctional anti-EpCAM×anti-CD3 antibody for the treatment of cancer patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)